Professional Documents
Culture Documents
Neurodegenerative disease[edit]
Neurodegenerative disease has been associated with disrupted circadian rhythms. Patients with
mild cognitive impairment (MCI) were shown to have advanced secretion of melatonin, awoke
more frequently after sleep onset and had a higher delay to rapid eye movement sleep.[1] This
suggests that patients that are more susceptible to dementia, especially the elderly, are likely to
have disrupted circadian rhythms even without a neurodegenerative disease.
Alzheimer's Disease[edit]
Over 40% of Alzheimer's Disease patients display symptoms of circadian misalignment,
including sundowning, excessive daytime sleepiness, nocturnal wandering, and day-night
reversal.[1]
Multiple Sclerosis[edit]
Fatigue is an important cause of disability in Multiple Sclerosis (MS) pathogenesis, and is found
in about 64% of patients. [2] Studies have recorded sleep disturbance and insomnia in about 58%
of patients and is associated with symptoms such as pain and nocturia. Although the exact cause
is unclear, one proposed mechanism of this phenomenon is the disruption of circadian rhythms.
[2]
Multiple Sclerosis has also been associated with abnormal circadian rhythms in body
temperature and subsequently periodic hyperthermia. [3]
Disruption[edit]
Circadian rhythm dysfunction has been shown to contribute to the progression of
neurodegenerative disease.[4] Disruption of rhythms in the secretion of melatonin has direct
effects on normal brain aging and neuropathological aging due to melatonin's roles in regulating
energy metabolism through signaling pathways with insulin and modulating epigenetics.[5]
Circadian dysfunction is also thought to contribute to Alzheimer's disease pathogenesis through
changes in amyloid- deposition. Accumulation of amyloid- plaques in the brain is an
important step in the progression of Alzheimer's, and human models show that amyloid-
concentrations rise during wakefulness and fall during sleep.[4] Disrupted sleep patterns may
contribute directly to the worsening of AD through disruption of the natural rise and fall of
amyloid-.
synthesized in the stomach which acts in the pituitary to stimulate energy homeostasis, cortisol
release, appetite, and weight gain, and is seen to rise just prior to eating.[7] Administering Ghrelin
to patients daily could help amplify the effects of food-entrainment to scheduled daily meals,
somewhat restoring circadian rhythmicity and benefitting Alzheimers patients.[7]